Literature DB >> 1041215

In vitro activity of penicillins against anaerobes.

F P Tally, N V Jacobus, J G Bartlett, S L Gorbach.   

Abstract

The in vitro susceptibility of 162 anaerobic isolates from clinical material were tested to pencillin G, BL-P1654, and carbenicillin. Penicillin G and BL-P1654 showed good activity against Bacteroides fragilis, but only 60% of strains were susceptible to carbenicillin at achievable blood levels (128 mug/ml).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1041215      PMCID: PMC429153          DOI: 10.1128/AAC.7.4.413

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Anaerobic infections of the female genital tract: bacteriologic and therapeutic aspects.

Authors:  H Thadepalli; S L Gorbach; L Keith
Journal:  Am J Obstet Gynecol       Date:  1973-12-15       Impact factor: 8.661

2.  The susceptibility of Bacteroides fragilis to 24 antibiotics.

Authors:  J W Kislak
Journal:  J Infect Dis       Date:  1972-03       Impact factor: 5.226

3.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

4.  Diagnosis and management of infections associated with immunosuppression. New antibiotics of potential importance for immunosuppressed patients.

Authors:  G P Bodey; V Rodriguez; N Horikoshi; M Valdivieso
Journal:  Transplant Proc       Date:  1973-09       Impact factor: 1.066

5.  Anaerobic infections. 1.

Authors:  S L Gorbach; J G Bartlett
Journal:  N Engl J Med       Date:  1974-05-23       Impact factor: 91.245

6.  Diagnostic features of clindamycin-associated pseudomembranous colitis.

Authors:  F J Tedesco; R J Stanley; D H Alpers
Journal:  N Engl J Med       Date:  1974-04-11       Impact factor: 91.245

7.  Antibiotic susceptibility testing of Bacteroides.

Authors:  S J Bodner; M G Koenig; L L Treanor; J S Goodman
Journal:  Antimicrob Agents Chemother       Date:  1972-08       Impact factor: 5.191

8.  The susceptibility of bacteroides to the penicillins and cephalothin.

Authors:  G T Keusch; C J O'Connell
Journal:  Am J Med Sci       Date:  1966-04       Impact factor: 2.378

9.  In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens.

Authors:  W J Martin; M Gardner; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

  9 in total
  7 in total

1.  Susceptibility testing of anaerobic bacteria with 100-microg carbenicillin disks.

Authors:  W W Laslie; D W Lambe
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

2.  Unique bactericidal action of metronidazole against Bacteroides fragilis and Clostridium perfringens.

Authors:  E D Ralph; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

3.  Anaerobic bacteria: evaluation of disc susceptibility to four cephalosporins.

Authors:  J Dubois; J C Pechère
Journal:  Infection       Date:  1978       Impact factor: 3.553

4.  Susceptibility of anaerobic bacteria to 23 antimicrobial agents.

Authors:  V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

Review 5.  Antimicrobial drugs used in the management of anaerobic infections in children.

Authors:  I Brook
Journal:  Drugs       Date:  1983-12       Impact factor: 9.546

6.  Effect of L-cysteine on the activity of penicillin antibiotics against Clostridium difficile.

Authors:  S M Markowitz; D S Williams
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

7.  Effect of antibiotic pre-treatment and pathogen challenge on the intestinal microbiota in mice.

Authors:  Tadasu Iizumi; Takako Taniguchi; Wataru Yamazaki; Geraldine Vilmen; Alexander V Alekseyenko; Zhan Gao; Guillermo I Perez Perez; Martin J Blaser
Journal:  Gut Pathog       Date:  2016-11-18       Impact factor: 4.181

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.